Literature DB >> 12575299

[Expression of TGF beta 1 and TGF beta RI proteins in tissues of salivary adenoid cystic carcinoma].

Feng Guo1, Xin-chun Jian, Rui-xue Cheng.   

Abstract

OBJECTIVE: To determine the possible role of TGF beta 1 and TGF beta RI in facilitating neoplastic progression in human salivary adenoid cystic carcinoma (ACC).
METHODS: The expression of TGF beta 1 and TGF beta RI protein in human salivary adenoid cystic carcinoma was detected by the streptavidin-peroxidase (S-P) immunohistochemical method, and their contents were compared with those of normal salivary gland tissues and salivary pleomorphic adenoma (PA).
RESULTS: 1. TGF beta 1 and TGF beta RI proteins were expressed in most ductal epithelial cells and myo-epithelial cells, but they were not expressed in the acinar epithelial cells of any normal glands examined; 2. TGF beta 1 and TGF beta RI proteins were expressed in the duct-like arranging tumor cells and other solid proliferating tumor cells of salivary pleomorphic adenoma, and no difference of their contents existed between PA and normal salivary gland tissues (P > 0.05); 3. The contents of TGF beta 1 in ACC were significantly higher than those in normal salivary glands (P < 0.01), while the contents of TGF beta RI in ACC were significantly lower than those in normal salivary glands (P < 0.01).
CONCLUSION: The abnormal expression of TGF beta 1 and TGF beta RI might play an important role in tumor genesis and the development of malignant salivary gland tumors such as ACC; the over-expression of TGF beta 1 and low-expression of TGF beta RI might involve the bad biological behavior of ACC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12575299

Source DB:  PubMed          Journal:  Hunan Yi Ke Da Xue Xue Bao        ISSN: 1000-5625


  1 in total

1.  Correlation between Transforming Growth Factor-β and Periapical Lesions in Patients with Chronic Apical Periodontitis.

Authors:  Xiujuan Li; Xuesong Han; Wenlei Yu; Xing Chen; Ying Wu; Linjie Lu
Journal:  J Healthc Eng       Date:  2022-03-22       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.